Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Shares Outstanding (2020 - 2025)

Oncology Institute (TOI) has disclosed Shares Outstanding for 3 consecutive years, with $72.0 million as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Shares Outstanding rose 1151.84% year-over-year to $72.0 million, compared with a TTM value of $72.0 million through Jun 2022, up 1151.84%, and an annual FY2021 reading of $163510.0, changed N/A over the prior year.
  • Shares Outstanding was $166640.0 for Q2 2022 at Oncology Institute, up from $163510.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $73.2 million in Q4 2021 and bottomed at $163510.0 in Q1 2022.
  • Average Shares Outstanding over 3 years is $13.3 million, with a median of $5.8 million recorded in 2020.
  • The sharpest move saw Shares Outstanding changed 0.0% in 2021, then skyrocketed 1151.84% in 2022.
  • Year by year, Shares Outstanding stood at $5.8 million in 2020, then tumbled by 97.16% to $163510.0 in 2021, then surged by 43922.31% to $72.0 million in 2022.
  • Business Quant data shows Shares Outstanding for TOI at $72.0 million in Q2 2022, $73.3 million in Q1 2022, and $163510.0 in Q4 2021.